Search Results - "Kawasaki, Rika"
-
1
European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients
Published in Cancer science (01-01-2014)“…The Sokal and Hasford scores were developed in the chemotherapy and interferon era and are widely used as prognostic indicators in patients with chronic…”
Get full text
Journal Article -
2
Successful Engraftment and Durable Graft-versus-host Disease Control with Haploidentical Peripheral Blood and a Short-term Conditioning Regimen for Primary Graft Failure
Published in Internal Medicine (01-01-2015)“…Primary graft failure occurred after cord blood transplantation for a patient with acute lymphoblastic leukemia. The second transplantation was performed using…”
Get full text
Journal Article -
3
Clinical significance of the administration of cytarabine or thiotepa in addition to total body irradiation and cyclophosphamide for allogeneic hematopoietic cell transplantation in patients with acute leukemia
Published in International journal of hematology (01-10-2015)“…A multicenter retrospective study was performed to determine the significance of adding cytarabine (CA) or thiotepa (TT) in the context of total body…”
Get full text
Journal Article -
4
人工膝関節置換手術後の悪心・嘔吐と食事摂取量に対するオンダンセトロンの効果の検討
Published in 日本臨床麻酔学会誌 (15-07-2023)Get full text
Journal Article -
5
Drug-induced liver injury after allogeneic bone marrow transplantation
Published in International journal of hematology (01-10-2013)“…A 23-year-old woman developed acute severe hepatitis and jaundice on day 183 after bone marrow transplantation from HLA-B antigen mismatched-related donor. The…”
Get full text
Journal Article -
6
Effect of bovine lactoferrin feeding on lipopolysaccharide-induced metabolic and hormonal disturbances in preruminant calves
Published in Animal science journal (01-06-2008)“…One of the biological functions of bovine lactoferrin (LF) is modulation of the host defense system, including cytokine production and immune response. The aim…”
Get full text
Journal Article -
7
Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy
Published in Rinshō ketsueki (01-04-2015)“…We retrospectively analyzed, and herein discuss, the outcomes of and prognostic factors for 35 untreated multiple myeloma patients less than 65 years of age…”
Get more information
Journal Article -
8
Totally Implantable Central Venous Access Port-Associated Bloodstream Infection Caused by Corynebacterium provencense: The First Case Report
Published in Curēus (Palo Alto, CA) (11-10-2024)“…Corynebacterium species are associated with healthcare-associated infections, specifically in device implantation. Here, we report a rare case of a 44-year-old…”
Get full text
Journal Article -
9
Efficacy and safety of a 5-day regimen of azacitidine for patients with high-risk myelodysplastic syndromes
Published in European journal of haematology (01-09-2016)“…Although a 7‐day (d) regimen of azacitidine (AZA) is the standard treatment of high‐risk myelodysplastic syndromes (MDS), AZA is difficult to administer during…”
Get full text
Journal Article -
10
Validation of the Composite End Point of Graft-Versus-Host Disease-Free, Relapse-Free Survival
Published in Biology of blood and marrow transplantation (01-03-2016)Get full text
Journal Article -
11
Effect of Ondansetron on Postoperative Nausea and Vomiting and Food Intake after Knee Arthroplasty
Published in Nihon Rinshō Masui Gakkai shi (15-07-2023)“…Patients who underwent knee arthroplasty under general anesthesia were evaluated for the incidence of postoperative nausea and vomiting(PONV)and food intake in…”
Get full text
Journal Article -
12
Efficacy and Safety of a 5-Day Regimen of Azacitidine for Patients with High-Risk Myelodysplastic Syndromes
Published in Blood (06-12-2014)“…Background: In the AZA-001 trial, azacitidine (AZA; 75 mg/m2per day for 7 consecutive days of every 28-day cycle) demonstrated improved survival compared with…”
Get full text
Journal Article -
13
The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma
Published in Leukemia & lymphoma (01-12-2016)“…We previously developed a prognostic index, SIL, which includes advanced stage (S), soluble interleukin-2 receptor level (I), and elevated lactate…”
Get full text
Journal Article -
14
Prognostic Impact Of Gender In Diffuse Large B Cell Lymphoma Patients Treated With R-CHOP Therapy
Published in Blood (15-11-2013)“…Since the introduction of rituximab, an anti-CD20 monoclonal antibody, the prognosis of patients with CD20-positive non-Hodgkin lymphoma has significantly…”
Get full text
Journal Article -
15
Preparation and Characterization of Polymer Microspheres Which Haye Specific Binding Ability for Saccharide Molecules
Published in Analytical sciences (01-10-1996)Get full text
Journal Article -
16
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy
Published in Leukemia research (01-02-2015)“…Highlights • Very few reports on outcome differences between SpD and InD lesions exist for DLBCL. • We evaluated outcome differences between SpD and InD in…”
Get full text
Journal Article -
17
Evaluation of Serum Lactate Dehydrogenase and Soluble Interleukin-2 Receptor in Malignant Lymphoma
Published in Blood (06-12-2014)“…Background: In lymphoma patients, it is believed that serum lactate dehydrogenase (LDH) reflects the tumor mass and that soluble interleukin-2 receptor…”
Get full text
Journal Article -
18
No Outcome Differences Were Observed Between Supra-Diaphragmatic and Infra-Diaphragmatic Lesions in Limited-Stage Diffuse Large B Cell Lymphoma Treated with R-CHOP Therapy, Whereas the Presence of Gastro-Intestinal Lesions Was Associated with a Favorable Prognosis
Published in Blood (06-12-2014)“…Background: Some studies evaluating differences in clinical features and outcome between supra-diaphragmatic (SpD) and infra-diaphragmatic (InD) primary…”
Get full text
Journal Article -
19
Prognostic Impact of Gender in Diffuse Large B Cell Lymphoma Patients Treated with R-CHOP Therapy
Published in Blood (06-12-2014)“…Background: Since the introduction of rituximab, an anti-CD20 monoclonal antibody, the prognosis of patients with CD20-positive non-Hodgkin lymphoma has…”
Get full text
Journal Article -
20
Effect of High Body Mass Index on the Prognosis of Diffuse Large B-Cell Lymphoma
Published in Blood (06-12-2014)“…Background Obesity has been pointed out as one of the risk factors for the development in several neoplastic diseases including malignant lymphoma. However the…”
Get full text
Journal Article